Cidara Therapeutics Inc.

San Diego, CA Part of Merck Sharp & Dohme LLC

UEI
FKP3JZ9RUNY9
CAGE
7A5L2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
6310 Nancy Ridge Dr #101, San Diego, CA 92121, USA
Website
merck.com
Founded
1891
Employees
50K-100K
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $58,051,984

Contract awards

Quick answers

Is Cidara Therapeutics Inc. registered in SAM.gov?

Yes. Cidara Therapeutics Inc.'s SAM.gov registration is active through July 6, 2027.

How much has Cidara Therapeutics Inc. received in federal contracts?

Federal contracts obligated $58,051,984 to Cidara Therapeutics Inc. in fiscal year 2025.

How does Cidara Therapeutics Inc. rank among federal contractors?

Cidara Therapeutics Inc. ranked #1 in PSC AN14, #8 in NAICS 541714 and #12 in PSC AN in FY2025.

What is Cidara Therapeutics Inc.'s most recent federal award?

Cidara Therapeutics Inc.'s most recent federal contract award is Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts… (75A50125C00017), from Office of the Assistant Secretary for Preparedness and Response, on September 30, 2025.

On GovTribe

See Cidara Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors